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1. Introduction
Macrophages and neutrophils are the sentinel cells of the innate immune response of verte‐
brates, such as bony fish (teleosts). As phagocytic myeloid cells, they are involved in homeo‐
static mechanisms, wound healing, and the detection, elimination and clearance of foreign
entities including tumors, virus-infected cells and invading pathogens. Furthermore, macro‐
phages and neutrophils are responsible for producing hundreds of bioactive molecules that
are important in pathogen recognition and destruction, cellular communication and activa‐
tion, initiation of an adaptive immune response and later, resolution of an inflammatory re‐
sponse and tissue repair. Neutrophils and macrophages, while essential to survival, have a
finite lifespan. Therefore, a manufacturing centre, the hematopoietic niche, is needed for the
production of myeloid cells. The hematopoietic niche must maintain basal myeloid cell pro‐
duction levels during homeostasis, yet retain the flexibility to ramp-up cell production in re‐
sponse to physiological demands, such as pathogenic insult. The development of
macrophages (monopoiesis) and neutrophils (granulopoiesis) is collectively known as mye‐
lopoiesis, and is regulated by the complex interaction of colony-stimulating factors (CSFs),
their receptors, and intracellular transcription factor machinery that control lineage fate de‐
cisions and terminal differentiation events.
Over the past 50 years, research using the mouse model system has culminated in the identi‐
fication of the site(s) of myelopoiesis, the progenitor cell types that give rise to mature mye‐
loid cells, the extracellular and intracellular cues required, and a detailed understanding of
the complex intracellular and extracellular milieu of factors that drive this tightly controlled
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process. From these studies we understand hematopoiesis as an exquisitely fine-tuned,
highly regulated, process whereby all blood cells develop from a small number of hemato‐
poietic stem cells (HSCs). HSCs are characterized as long-term repopulating, pluripotent,
quiescent cells that undergo symmetrical self-renewal to sustain the population of HSCs
within the hematopoietic niche, or asymmetrical division to give rise to hematopoietic pro‐
genitor cells (HPCs) [1]. HPCs can develop along the lymphoid lineage, termed lymphopoi‐
esis, to give rise to B-cells, T-cells, natural killer (NK) cells and dendritic cells (DCs).
Alternatively, HPCs can develop along an erythroid lineage, termed erythropoiesis, to give
rise to erythrocytes and megakaryocytes, or develop along a myeloid lineage to give rise to
granulocytes (neutrophils, basophils, eosinophils, mast cells), mononuclear phagocytes
(monocytes and macrophages), and DCs. The lymphoid lineage represents the adaptive arm
of the immune response, while the myeloid lineage represents the innate arm of the immune
response. Regardless of lineage, the decisions made to commit and develop along a given
lineage are controlled by extracellular growth factors and intracellular transcription factors
that act in concert to regulate gene and protein expression to achieve the desired outcome.
When compared to  the  mechanisms of  myelopoiesis  in  the  mouse,  studies  using  lower
vertebrates, such as teleosts, have identified both evolutionary conservation as well as di‐
vergence in the mechanisms of myelopoiesis. With over 30,000 identified species, teleosts
are the most expansive class of  vertebrates,  and represent an excellent  model system to
study the evolution of  vertebrate  myelopoiesis  as  they are  one of  the ancient  classes  of
vertebrates to retain the production of myeloid cells. Within the teleost system, much re‐
search  surrounds  the  characterization  of  teleost  cytokines  and receptors  involved in  in‐
flammation  and  their  cellular  targets  (primarily  macrophages).  In  comparison,  little  is
known about  the  mechanisms that  govern myeloid  cell  production.  Research on teleost
myelopoiesis  is  hampered by the lack of  reagents,  the difficulty in isolating appreciable
numbers  of  relatively  pure  populations  of  HSCs/HPCs,  and  in  identifying  key  growth
factors  important  for  myeloid cell  development  due to  evolutionary selection pressures.
As such, the focus of this review is to provide an overview of the current knowledge of
the fish model  systems used and the growth factors,  receptors  and transcription factors
involved in teleost myelopoiesis,  using information from the mammalian model systems
as a scaffold to put the advances into context.
2. Teleost model systems of myelopoiesis
2.1. Zebrafish model system
The zebrafish model has been instrumental in advancing our knowledge of the sites of hem‐
atopoiesis/myelopoiesis in teleosts, the development, differentiation and migration of HSCs,
and through genetic manipulation, the characterization of the early acting growth factors,
receptors and transcription factors involved in hematopoiesis. By far, the major advantage
provided by zebrafish is the ease of generating transgenic zebrafish, morphant zebrafish
(morpholinos) and knockout zebrafish (zinc finger nucleases), as well as many others, due to
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genetic manipulation. In conjunction, the rapid generation of embryos, embryonic transpar‐
ency, and small embryo size allows for mass screening strategies. The advantages of zebra‐
fish as a model system, and their contributions to hematopoiesis have been extensively
reviewed elsewhere [2-5], and thus will not be covered in this review. While the zebrafish is
an excellent in vivo model, it does not lend itself to ex-vivo studies due to the small size of the
fish and the difficulty of isolating sufficient number of cells for in vitro studies.
2.2. Ginbuna crucian carp model system
In vivo transplantation to test the repopulation activity of donor cells has been the gold
standard for the characterization of HSCs and HPCs [6-9]. In cyprinid fish, there is a unique
transplantation model system for detecting HSCs and HPCs using clonal ginbuna crucian
carp (Carassius auratus langsdorfii, S3n strain) and ginbuna-goldfish (Carassius auratus) hy‐
brids (S4n strain). Ginbuna crucian carp have advantages for transplantation experiments
because they are easily maintained, tolerate handling and are large enough to allow for the
collection of sufficient hematopoietic cells. Clonal ginbuna are unisexual triploid fish (all fe‐
male, 3n = 156) that principally reproduce gynogenetically. A unique clone (S3n) can repro‐
duce by not only gynogenesis but also bisexual reproduction. When eggs from the S3n clone
are inseminated with UV-irradiated goldfish sperm, triploid clones result. In contrast, when
the eggs are inseminated with normal goldfish sperm, tetraploid hybrids (S4n) are obtained
[10]. These S4n fish possessed four sets of chromosomes, three from the S3n clone and one
from the goldfish. Therefore, when the cells from S3n clones are transferred into S4n recipi‐
ents, transplants are accepted, whereas the reverse transplants are rejected [11, 12]. More‐
over, the donor cells in the recipient tissues are easily distinguished by their difference in
DNA content by flow cytometric analysis (ploidy analysis) [13].
The ginbuna crucian carp model system has been instrumental in serving as a close parallel
to the mouse model system in terms of hematopoietic reconstitution experiments to demon‐
strate the existence of HSCs in teleosts. Identification of donor and recipient HSCs/HPCs
and characterization of their progeny by ploidy analysis is useful for assessing the multipo‐
tency of different progenitor cell populations. Furthermore, the use of this model system has
allowed for the determination of the location of HSCs within the hematopoietic organs of
cyprinids. Use of the ginbuan crucian carp system will be particularly important for future
work as antibodies are developed against markers on the surface of fish HSCs and HPCs to
allow for the analysis of the potency of progenitor cell subpopulations.
2.3. Goldfish model system
The goldfish model system represents a unique opportunity to study myelopoiesis in vitro.
Firstly, teleost monopoiesis can be examined using the previously developed primary kid‐
ney macrophage (PKM) culture system [14, 15] and has provided information on the growth
factors, receptors, and transcription factors involved. Secondly, large numbers of relatively
pure neutrophils can be isolated from the goldfish kidney [16] and represents a starting
point for studying granulopoiesis in goldfish and will be discussed in the following sections.
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Together, these two model systems will prove instrumental in understanding the factors
that regulate teleost myelopoiesis.
In the in vitro PKM system, small mononuclear cells isolated from the goldfish kidney prolif‐
erated and differentiated over 8-10 days giving rise to three cell sub-populations, R1-, R2-
and R3-gated cells [14, 15]. The cytochemical, molecular and functional characterization of
these cell sub-populations demonstrated the presence of putative progenitor cells (R1 gate),
monocytes (R3 gate), and mature macrophages (R2 gate). These three cell sub-populations in
PKM cultures represent distinct junctures of macrophage development simultaneously oc‐
curring in vitro [14, 15].
The  spontaneous  proliferation and differentiation of  PKMs suggested the  production of
endogenous growth factors and prompted the examination of the target cell sub-popula‐
tion(s)  upon which they acted and their  effects  on cell  proliferation and differentiation.
The putative progenitors (R1 cells) and macrophages (R2 cells), but not monocytes, were
determined to be responsible for the production of endogenous growth factors that act in
an autocrine and paracrine fashion [15].  Addition of  cell-conditioned medium (CCM) to
sorted cell populations demonstrated the capacity of putative progenitors and monocytes
to proliferate and differentiate in response to endogenous growth factors. However, treat‐
ment of  macrophages (R2 cells)  with CCM demonstrated their  apparent  terminal  differ‐
entiation, while their capacity to proliferate suggested they were capable of self-renewal
[15,  17].  Clearly,  different  endogenous growth factors  present  in  CCM exert  distinct  ac‐
tions on macrophage cell sub-populations.
Two pathways of macrophage development were proposed to occur in the PKM cultures.
The predominant pathway was classical macrophage development in which progenitor cells
differentiated into monocytes and then macrophages [17]. The second was an alternative
pathway of macrophage development in which progenitor cells differentiated into macro‐
phages without a prominent monocytic stage [17]. The possible retention of the alternative
pathway of macrophage production in addition to the classical pathway may provide a
mechanism for rapid generation of macrophages during injury or infection in vivo.
The observed kinetics of the PKM cultures suggested three phases of growth. Initially, there
is a lag phase (days 1-4) where many cells die, followed by a proliferative phase (days 5-9)
where cell numbers rapidly increase [14], and finally, a senescence phase (days 10-14) char‐
acterized by cell clumping and cell apoptosis [17, 18]. Differential cross screening of prolifer‐
ative versus senescence phase PKMs identified a number of differentially expressed genes
including those involved in hematopoiesis, signal transduction, transcription, translation
and protein processing [19]. The involvement of the identified transcripts in the regulation
of cell development [20-22] will be discussed in the following sections.
These seminal observations from PKM cultures established three important ideas regarding
goldfish monopoiesis: (1) kidney leukocytes produce their own endogenous growth factors
important for driving proliferation and differentiation [14, 15]. (2) Within the population of
small leukocyte R1 cells, a population of macrophage progenitor cells must exist. (3) Unlike
mammalian systems, the progenitor cell population gives rise to fully differentiated macro‐
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phages in vitro in the absence of exogenous growth factors. Thus, the goldfish PKM model
system allows for comprehensive analysis of the interactions between developing macro‐
phage subpopulations in vitro.
3. Site of hematopoiesis/myelopoiesis
3.1. Two waves of hematopoiesis in vertebrates
There are two waves of hematopoiesis in vertebrates. The first wave is primitive hematopoi‐
esis and occurs during embryonic development. Definitive hematopoiesis follows primitive
hematopoiesis and occurs in the post-natal or adult animal. Primitive and definitive hemato‐
poiesis are different on a temporal scale, a spatial scale, and in the types of cellular progeny
generated. With the exception of T-cells, that undergo maturation in the thymus, lympho‐
poiesis and myelopoiesis occur in the major hematopoietic organs. The major hematopoietic
organ of teleosts is the kidney, akin to that of mammalian bone marrow.
3.2. Primitive myelopoiesis in teleosts
The development of myelopoiesis in fish has primarily been studied using the zebrafish
model system. Primitive myelopoiesis is predominated by HPCs with primarily erythroid
and myeloid development potential. Initially, primitive hematopoiesis is initiated in the an‐
terior lateral mesoderm (ALM), that gives rise to the rostral blood island (RBI), and in the
posterior lateral mesoderm (PLM), that gives rise to the intermediate cell mass (ICM). The
RBI is the site of primitive myeloid cell development, generating primarily primitive macro‐
phages that undergo rapid differentiation, lacking or having a very short monocytic stage
[23] and a few neutrophils [24], while the ICM is the site of primitive erythroid cell develop‐
ment [25]. This stage of primitive hematopoiesis occurs early during development of zebra‐
fish, approximately 11 hours post fertilization (hpf). Following the onset of circulation, at
around 24 hpf, the site of hematopoiesis then switches to the posterior blood island (PBI)
[26] and produces multi-lineage progenitor cells capable of producing both primitive eryth‐
roid and myeloid cells [27]. Primitive macrophages act as phagocytes during tissue remodel‐
ing throughout embryonic development and in clearance of bacterial pathogens [23]. While
primitive neutrophils also migrate to a site of infection, they were not observed to phagocy‐
tose bacteria [24]. The temporal, spatial and transcriptional control of zebrafish primitive
hematopoiesis has been reviewed by [28-30]. Differences in the initial site of hematopoiesis
occur between fish species, however, the production of erythrocytes and macrophages dur‐
ing primitive hematopoiesis is consistent [31, 32].
3.3. Definitive myelopoiesis in teleosts
The onset of definitive myelopoiesis occurs around 36 hpf in the zebrafish. Here, HSCs seed
the aorta-gonad-mesonephros (AGM) and the caudal hematopoietic tissue (CHT) [33, 34].
By 48 hpf, the HSCs seed the kidney [33], the final hematopoietic site equivalent to mamma‐
lian bone marrow [35-37].
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The existence of teleost kidney HSCs and HPCs capable of generating all hematopoietic line‐
ages was demonstrated using transplantation studies in zebrafish and ginbuna crucian carp.
Transplantation of whole kidney marrow from gata1eGFP zebrafish into pre-thymic vlad tepes
(gata1-/-) zebrafish [37] or whole kidney marrow from β-actineGFP zebrafish into lethally irradi‐
ated zebrafish [38], resulted in rescue of the phenotype and produced lymphoid and mye‐
loid cell types suggestive of the presence of HSCs capable of long-term reconstitution.
However, these studies were complicated by the use of whole kidney marrow during trans‐
plantation. Using ginbuna crucian carp, HSCs, found to be associated with the trunk kidney
renal tubules, were identifiable by their ability to efflux Hoechst 33342 using the ATP-bind‐
ing cassette (ABC) transporter, ABCG2a, and HPCs were identified by their ability to efflux
rhodamine 123 by another ABC transporter, P-glycoprotein [39-42]. HSCs, consisting of
0.33% ± 0.15 of the total body kidney cells, were capable of engraftment and long-term pro‐
duction (>9 months) of all hemopoietic progeny, including erythrocytes, granulocytes, mon‐
ocytes, thrombocytes and lymphocytes [40, 41, 43]. HPCs, while they could also give rise to
all hemopoietic progeny, were only capable of short-term reconstitution [42]. However, en‐
graftment of donor HSCs and HPCs only occurred in anemia-induced or gamma irradiated
recipients [40, 43, 44] suggesting that space within the hematopoietic niche is required for
successful engraftment of HSCs to occur [40, 43]. Experiments using zebrafish and ginbuna
crucian carp provide strong evidence that the teleost trunk kidney contains HSCs and HPCs
capable of multi-lineage differentiation, including myelopoiesis [45].
4. Commitment to the myeloid lineage
4.1. Progression of cell development
From  the  mouse  model  we  know  that  the  commitment  of  a  pluripotent,  self-renewing
HSC to  a  common myeloid progenitor  (CMP) is  a  progression of  lineage fate  decisions
controlled by extracellular  cues,  such as  growth factors,  within  the  hematopoietic  niche
[46-48],  as well  as the modulation of intracellular transcription factors [49-52].  The proc‐
ess  of  committing to a  CMP begins with long-term HSCs (LT-HSCs),  capable of  self-re‐
newal and multi-lineage differentiation. LT-HSCs give rise to short-term HSCs (ST-HSCs)
with limited capacity for self-renewal, which then differentiate into multipotent progeni‐
tors  (MPPs)  with no ability  to  self-renew,  reviewed by [53].  The MPPs can give rise  to
the CMP or the lymphoid-myeloid primed multipotent progenitors (LMPPs) [54-57]. The
CMP  can  differentiate  into  megakaryocyte/erythroid  progenitor  (MEP)  or  to  a  granulo‐
cyte/macrophage  progenitor  (GMP)  [58]  (Figure  1).  The  LMPPs  can  differentiate  into  a
common lymphoid precursor (CLP) that gives rise to T- and B-lymphocytes,  or can also
give rise to GMPs [54-57, 59, 60], and reviewed in [61].
On the other hand, the “myeloid-based model” of hematopoiesis, in which myeloid poten‐
tial is retained in erythroid, T, and B cell branches even after these lineages have segregated
from each other, has been proposed [62]. Notably, there is no CLP in this model [63-65]. Ac‐
cording to this model, hematopoiesis can be understood as follows: specification toward er‐
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ythroid, T, and B cell lineages proceeds on a basis of a prototypical developmental program
to construct myeloid cells [66, 67]. Indeed, several findings in teleosts are supportive of the
myeloid-based model [68, 69]. In the future, the myeloid-based model may bring a para‐
digm shift in the concept of blood cell lineage development. In the following sections the
key growth factors and transcription factors studied in the teleost system will be discussed.
Figure 1. Growth factors and their receptors involved in goldfish myelopoiesis. Goldfish growth factors are shown in
uppercase lettering, goldfish growth factor receptors/surface receptors are shown in uppercase italics lettering, and
growth factors and their receptors important in mammalian myelopoiesis, but have yet to be identified in teleosts are
shown in uppercase italics. The dashed arrow denotes the alternative pathway of macrophage development in gold‐
fish, the solid curved arrows denote negative regulation of macrophage development by sCSF-1R. Question marks de‐
note the hypothesized role of growth factors or receptors and further studies are required to test the hypothesis.
Asterisks mark differences between teleosts and mammals. Abbreviations used: (1) Cellular stages: HSC, hemato‐
poietic stem cell; CMP, common myeloid progenitor; GMP, granulocyte-macrophage progenitor; M, monocytic precur‐
sor; G, granulocytic precursor. (2) Growth factors: KITLA, kit ligand a; IL-3, interleukin 3; GM-CSF, granulocyte-
macrophage colony-stimulating factor; CSF-1, colony-stimulating factor 1 (macrophage colony-stimulating factor);
GCSF, granulocyte colony-stimulating factor; GF, growth factor. Receptors: IL-3R, interleukin 3 receptor; GM-CSFR,
granulocyte-macrophage colony-stimulating factor receptor; CSF-1R, colony-stimulating factor-1 receptor (macro‐
phage colony-stimulating factor receptor); sCSF-1R, soluble colony-stimulating factor-1 receptor; GCSFR, granulocyte
colony-stimulating factor receptor.
4.2. Receptors and growth factors
4.2.1. Mammalian stem cell factor and Kit receptor
Stem cell factor (SCF) was identified [70-72] as short-chain four-helix bundle [73] encoded
by the Steel locus in the mouse [74]. Mutations in the Steel locus were associated with defects
in stromal cells, and resulted in reduced numbers of HSCs and HPCs [75]. The SCF gene
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produces two alternatively spliced mRNAs that differ in the presence or absence of exon 6
[71]. Although the two SCF splice variants can be expressed in the same tissues, they have
tissue specific regulation of expression [71, 76]. Both SCF isoforms are produced as exten‐
sively glycosylated [77, 78] membrane bound forms (mSCF) that can undergo proteolytic
cleavage to produce a soluble form of SCF (sSCF) [79, 80]. In human blood, sSCF is at a con‐
centration of 3.0 ± 1.1 ng/mL [77]. Alternatively, mSCF may provide a means for cell-to-cell
contact with the stromal cells in the hematopoietic niche [71], and may act to increase the
signal strength provided to the HSC/HPCs, reviewed in [81]. Both mSCF and sSCF are capa‐
ble of forming dimers [78, 82] and signal through their receptor, c-KIT.
The  SCF  receptor,  c-KIT  (CD117),  was  first  identified  as  the  cellular  oncogene  (c-onc)
equivalent of the viral  oncogene (v-onc),  v-Kit,  isolated from the Hardy-Zuckerman 4 fe‐
line  sarcoma  virus  [83].  Based  on  structural  analysis,  the  c-KIT  protein  was  grouped
within the Type III  tyrosine kinase receptor family that  includes colony-stimulating fac‐
tor-1 receptor (CSF-1R), platelet derived growth factor receptor (PDGFR), and FLT3/FLK2
receptor [84-87]. Studies mapped c-KIT  to the White  locus (W) in the mouse [74, 83], and
demonstrated that  mice with mutations in the White  or  Steel  loci  exhibit  hypopigmenta‐
tion, mast cell deficiency, macrocytic anemia, and sterility, while the complete loss of ei‐
ther of these genes was lethal [74, 88].
The c-KIT protein is primarily found on hematopoietic cells and is a marker of long-term re‐
constituting HSCs in humans [89] and mice [90-92]. c-KIT is expressed on pluripotent and
multipotent HSCs and myeloerythroid precursors, but not on differentiating or mature cell
types [90-92], with the exception of mast cells [93]. Approximately 2 x 104 c-KIT receptors are
found on normal human HPCs [94], and can undergo proteolytic cleavage to release a solu‐
ble form of c-KIT [95-97]. The soluble c-KIT receptor is thought to regulate membrane bound
c-KIT activity, in vivo, by blocking SCF binding [95, 98].
Binding of homodimeric SCF to c-KIT results in receptor homodimerization, conformational
changes in the extracellular and intracellular domains and autophosphorylation of the intra‐
cellular tyrosines (reviewed extensively in [73, 78, 99-105]) leading to a number of down-
stream signaling pathways that mediate the action of SCF through c-KIT. These signaling
pathways include phosphatidylinositol-3-kinase (PI3K), phospholipase Cγ (PLCγ), mem‐
bers of the Janus family of protein tyrosine kinases (JAK) and signal transducers and activa‐
tors of transcription (STATs), Src family members, the Ras/Raf/MAP kinase pathway, and
others. The signaling pathway initiated depends on the cell type, and the strength and dura‐
tion of the signal, reviewed in [106-108].
4.2.2. Biological functions of stem cell factor
SCF and its type III tyrosine kinase receptor c-KIT, are involved in hematopoiesis [81, 107,
108], spermatogenesis [109-111], and development of melanocytes [110, 112-114] and mast
cells [93, 96, 115-120]. Within the hematopoietic niche, one role of SCF/c-KIT is to mediate
HSC and HPC survival, important for the generation of spleen, interleukin-3 (IL-3), granulo‐
cyte/macrophage, and macrophage colony-forming units (CFU-S, CFU-IL-3, CFU-GM, and
CFU-M) [121]. Further studies have confirmed SCF/c-KIT to mediate the survival of long-
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term HSCs by blocking cell cycling or by inhibiting apoptosis [122, 123]. Furthermore, SCF
can synergizing with other growth factors, such as granulocyte-macrophage colony-stimu‐
lating factor (GM-CSF) [124], granulocyte colony-stimulating factor (G-CSF), IL-1, IL-3 [98],
IL-6, and IL-7, among others, to promote the proliferation and differentiation of HPCs [125,
126] and reviewed in [101]. Often, the progeny of HPC differentiation depends on the partic‐
ular growth factor and SCF. Lastly, SCF acts as a homing signal to HPCs, such as CFU-
GEMM (granulocyte-erythrocyte-macrophage-megakaryocyte), CFU-GM, CFU-Meg
(megakaryocyte) and burst forming units-erythrocyte (BFU-E) [127]
4.2.3. Teleost Kit and Kit ligand
Whole genome duplication has resulted in two orthologues of c-KIT and SCF in teleosts. Tel‐
eost orthologues of c-KIT, termed kit a (kita) and kit b (kitb), were first identified in zebrafish
and have subsequently been predicted from genomic analysis of Takifugu rubripes and Tet‐
raodon nigroviridis [128, 129]. The kita orthologue has also been identified and characterized
in Carassius auratus [130]. The two orthologues of mammalian SCF are termed kit ligand a
(kitla) and kit ligand b (kitlb) [128, 131]. The kitla and kitlb have been identified in zebrafish,
and predicted in fugu, medaka, and stickleback genomes [131]. The kitla orthologue has
been identified and characterized in goldfish [130].
Zebrafish kita, located on chromosome 20, and kitb, located on chromosome 1, are the ortho‐
logues of human and mouse c-KIT [128, 129]. Both kita and kitb genes contain 21 exons, how‐
ever, their respective proteins only retain 55% identity to each other [129]. The partitioning
of gene distribution and function was proposed to explain the retention of kita and the du‐
plicated gene, kitb [128, 129]. From studies on developing zebrafish, kita is expressed in hem‐
atopoietic progenitors, melanoblasts and melanocytes derived from the neural crest, along
the lateral line, the notochord and pineal gland [128, 129]. The expression of kitb occurs by 9
hpf and does not overlap that of kita. Instead, kitb expression is restricted to the Rohon-
Beard neurons, trigeminal ganglia, and otic vesicle [129]. Together, the expression of kita and
kitb approximates that of c-KIT in the mouse model system, with the notable exception of c-
KIT expression in primordial germ cells (PGCs).
The kitla gene is located on chromosome 25 and the kitlb gene is located on chromosome 4 of
the zebrafish genome [132]. Kitla has 9 exons while kitlb has 8 exons [131]. The nine kitla
exons correspond to the 9 exons of mammalian SCF isoform 1, including exon 6 which al‐
lows for cleavage of membrane bound SCF into a soluble form [131]. However, kitlb appears
to correspond to SCF isoform 2, in which exon 6 has been spliced out. The expression of kitla
is first observed at 19 hpf in the zebrafish and is found in the developing tail bud, pineal
gland, sensory epithelium of the ear, ventral otic vesicles, and in the somites [131]. Similar to
the expression of goldfish kita, kitla showed constitutive mRNA levels in tissues [130] and
this expression pattern was similar to what was observed in adult zebrafish tissues [132].
Goldfish kitla showed high levels of mRNA in isolated putative progenitor cells and mono‐
cytes compared to macrophages [130]. Zebrafish kitlb mRNA expression was observed in the
brain ventricles, ear and cardinal vein plexus and at lower levels in the skin as zebrafish de‐
velopment progressed [131].
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4.2.4. Biological functions of teleost kit ligands and receptors
Based on the non-overlapping expression of kita and kitb, the functional roles of c-KIT in
mammals may be partitioned between teleost KITA and KITB. The zebrafish mutant sparse,
shown to map to kita [128], or kitw34 mutants [133] show defects in their pigmentation pat‐
tern. Zebrafish KITA was shown to be involved in the dispersion and maintenance of mela‐
nocytes [128], and may play a transient role in melanocyte differentiation when melanoblast
development is perturbed [134]. Furthermore, knock-down of zebrafish kitla or kitlb using
morpholinos supported the involvement of KITLA in the migration and survival of melano‐
cytes [131]. Teleost kit expression in melanocytes has been implicated in the pigment pattern
formation in a number of fish species [128, 135-137] and suggests that the functions in mye‐
locyte development have been partitioned to the kita orthologue.
The role of teleost kita/kitla and kitb/kitlb during hematopoiesis is not clear. Examination of
hematopoiesis in zebrafish sparse mutants revealed no obvious defects in hematopoiesis dur‐
ing development. Although, slight decreases in promyelocyte and neutrophil cell numbers,
and slight increases in band cells and monocytes were observed in the kidney [128]. In addi‐
tion, zebrafish injected with kitla morpholinos or kitlb morpholinos also did not show defects
in hematopoiesis. However, studies in the goldfish model system demonstrated the expres‐
sion of kita mRNA in isolated kidney progenitor cells, and the functional role of goldfish KI‐
TLA in progenitor cell chemotaxis, proliferation, and maintenance [130]. Taken together,
these data suggest that KITA and KITLA proteins play a central role in myelopoiesis (Figure
1). However, redundancy between the two ligands and receptors may account for the ab‐
sence of hematopoietic defects in the zebrafish system, or there may be redundancy with an‐
other tyrosine kinase receptor. Additionally, the absence of hematopoietic defects in the
zebrafish may represent KIT-independent and KIT-dependent stages of hematopoiesis. The
function of KITLB and KITB during hematopoiesis in teleosts remains to be determined.
Lastly,  c-KIT plays  a  role  in  the  development  of  primordial  germ cells  (PGCs)  in  mice.
Examination of  primordial  germ cell  development in fish revealed that  kita  and kitb  ex‐
pression was not detected in PGCs,  and suggests teleost  KITs do not play a role in the
development of PGCs [128, 129]. However, it appears that kita,  kitb,  kitla  and kitlb  play a
role in ovarian folliculogenesis in zebrafish and provides evidence of neofunctionalization
of these genes [132].
4.2.5. Interleukin-3 and Interleukin-3 receptor
Interleukin-3 (IL-3) is a multi-lineage colony-stimulating factor (multi-CSF) that acts through
the IL-3 receptor alpha and common beta chain on multipotent erythro/myeloid HPCs to
promote their self renewal, proliferation and differentiation [138-140]. IL-3 can also act on
committed myeloid progenitors to promote their proliferation and differentiation [138-142].
Interestingly, IL-3, IL-4, IL-5 and GM-CSF are all found on chromosome 5q in humans. The
close proximity of the CSFs on the chromosome, along with their similar structure and func‐
tion may suggest they arose from a common ancestral gene [143]. However, genes encoding
IL-3 and the specific IL-3 receptor alpha (IL-3Rα) have not been identified in any teleosts to
date, despite genome sequencing (Figure 1). The lack of IL-3 in teleosts may be due to diffi‐
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culties in identifying the IL-3 orthologue in teleosts due to the low sequence conservation of
IL-3 observed between mammals, or may represent the evolutionary loss of IL-3 in teleosts.
As IL-3 and IL-3R have not been identified in teleosts, IL-3 and IL-3R will not be discussed
here. The structure, function and regulation of mammalian IL-3 and its receptor have been
extensively reviewed elsewhere by [144-146].
4.2.6. Granulocyte-macrophage colony-stimulating factor/Granulocyte-macrophage colony-
stimulating factor receptor
GM-CSF shares redundancy with IL-3 in terms of its function. However, GM-CSF acts on a
more mature population of HPCs and has been associated with the formation of both granu‐
locyte and macrophage colonies from CFU-GM [147, 148]. GM-CSF is produced by activated
T-lymphocytes [147, 149], endothelial cells [150], and lung fibroblasts [151] and suggests the
importance of GM-CSF during emergency hematopoiesis. GM-CSF promotes the survival,
proliferation and differentiation of GMPs [147, 148, 152]. Furthermore, GM-CSF is chemoat‐
tractive to immature and mature neutrophils in vitro and in vivo [153, 154] and enhances
neutrophil anti-microbial functions and neutrophil survival [155]. GM-CSF can also promote
monocytes to differentiate into inflammatory dendritic cells [156, 157]. The GM-CSF recep‐
tor (GM-CSFR) is composed of heterodimeric alpha and beta chains as described for IL-3.
Since the βc chain is common to IL-3, IL-5 and GM-CSF, the βc chain signals through JAK/
STAT, MAPK, and PI3K pathways [145, 158].
Similar to that of IL-3, GM-CSF has not been identified in teleosts (Figure 1). The close prox‐
imity of IL-3 and GM-CSF on the same chromosome may suggest that a genomic deletion
occurred on this chromosome, subsequent to the divergence of fish and mammals. The hem‐
atopoietic CSFs that compensate for the loss of IL-3 and GM-CSF in teleosts are not known.
4.3. Transcription factors
Commitment of LT-HSCs to the myeloid lineage is an intricate regulation of the transcrip‐
tion factors expressed, their relative levels to one another, and their expression on a tempo‐
ral scale. Transcription factors (TFs) can act antagonistically or co-operatively. Thus, the
presence or absence of a TF partner, or the relative levels of a TF to its antagonistic counter‐
part, determine lineage fate decisions. Furthermore, the expression of a transcription factor
in an HSC does not exert the same effect as when it is expressed in a committed progenitor
cell. The transcriptional regulation of mammalian hematopoiesis/myelopoiesis has been ex‐
tensively reviewed elsewhere [159-162], and will only be briefly described here for the pur‐
pose of putting advances in the teleost model systems into context. A visual representation
of which stages these transcription factors are important is shown in Figure 2.
4.3.1. MafB
MAFB, a bZIP transcription factor family member, is highly expressed in LT-HSCs, but not
in MPPs, CMPs, or GMPs and was recently found to be involved in restricting proliferation
and myeloid lineage differentiation of LT-HSCs [163]. MAFB-/- LT-HSCs showed increased
Regulation of Teleost Macrophage and Neutrophil Cell Development by Growth Factors and Transcription Factors
http://dx.doi.org/10.5772/53589
107
proliferative activity and gave rise to large numbers of primarily myeloid progeny in a
mouse repopulation assay [163]. The MAFB-/- HSCs had higher proliferative ability and
gives rise to greater numbers of myeloid progeny in response to CSF-1 compared to wild
type HSCs, in vitro. Furthermore, in vitro studies demonstrated that treatment of MAFB-/-
HSCs with CSF-1 led to the rapid activation of PU.1 transcription that suggested MAFB
must be down-regulated to allow expression of PU.1 in MPPs [163]. It appears that MAFB
plays an important role in antagonizing the expression of PU.1 and the commitment of
MPPs to CMPs. Furthermore, MAFB has been shown to bind ETS-1 though its zipper-bind‐
ing domain and can act to repress erythroid lineage commitment in CMPs [164].
Figure 2. Transcription factors involved in goldfish myelopoiesis. Goldfish transcription factors shown in lower case
lettering are up-regulated, goldfish transcription factors shown in bold are down-regulated, transcription factors that
are important in cellular differentiation in mammalian systmes but have yet to be studied in the teleost system are
shown in italics. The dashed arrow denotes the alternative pathway of macrophage development in teleosts. Question
marks denote unknown transcription factors involved in the alternative pathway of macrophage development. Aster‐
isks mark differences between teleosts and mammals. Abbreviations used: (1) Cellular stages: HSC, hematopoietic
stem cell; CMP, common myeloid progenitor; GMP, granulocyte-macrophage progenitor; M, monocytic precursor; G,
granulocytic precursor. (2) Transcription factors: c-MYB, cellular myelobastosis oncogene; EGR-1, early growth re‐
sponse-1; MAFB, musculoaponeurotic fibrosarcoma oncogene homologue B; GATA2, GATA binding protein 2; IRF8,
interferon regulatory factor 8; CEBPα, CCAAT/enhancer-binding protein alpha; GFI1, growth factor independent 1;
RUNX1, runt-related transcription factor 1.
In zebrafish, the mafb orthologue has been identified and mRNA was found expressed in the
blood forming regions of the developing embryo [165]. However, the role of MAFB in zebra‐
fish HSCs has not yet been assessed.
New Advances and Contributions to Fish Biology108
4.3.2. C/EBPs
CCAAT/enhancer binding proteins (C/EBPs) are members of the family of transcription fac‐
tors that contain a C-terminal basic leucine zipper domain (bZIP) comprised of a basic re‐
gion involved in DNA binding and a leucine zipper domain involved in protein interactions
[166]. Six members of the C/EBP family have been identified in mammals: alpha, beta, gam‐
ma, delta, epsilon and zeta [167]. Orthologues of the C/EBP family of transcription factors
have been identified in teleosts [168-171], corresponding to C/EBPα, C/EBPβ, C/EBPγ, C/
EBPε, and C/EBPδ.
Expressed in HSCs, CMPs and GMPs [172, 173], C/EBPα has been shown to be involved in
directing granulocyte cell fate and terminal differentiation of neutrophils, along with C/
EBPε. Mice deficient in C/EBPα show diminished numbers of CFU-GM, CFU-M, CFU-G,
macrophages and neutrophils [174, 175]. The loss of myeloid cells in C/EBPα deficient mice
is reflective of the role that CEBPα plays in determining the fate of a CMP to a GMP lineage
versus an MEP lineage [176]. C/EBPα is capable of binding to the PU.1 promoter [175] and
up-regulating PU.1 expression, to dictate a GMP cell fate [175, 177] (see discussion on PU.1
below). The increase in C/EBPα in GMPs has been shown to inhibit monocyte/macrophage
differentiation [178] and initiate differentiation along the granulocyte lineage by regulating
GCSFR, elastase and myeloperoxidase gene expression [179-181].
The zebrafish CEBPα orthologue showed 66% amino acid identity to human C/EBPα, while
the bZIP domains showed 99% amino acid identity [168]. In zebrafish, cebpa was expressed
in myeloid cells on the surface of the yolk sac during embryogenesis [168]. At 16 hpf, a pop‐
ulation of blood cells co-expressed the transcription factors gata1, pu.1 and cebpa, and by 22
hpf, the majority of the cebpa+ cells co-expressed pu.1, however, not all pu.1+ cells expressed
cebpa [182]. Furthermore, cebpa was co-expressed with myeloperoxidase (mpo), a marker for
granulocytes, but cebpa+ cells did not always express mpo [182]. These three cell sub-popula‐
tions likely represent distinct junctures in myeloid cell development: erythromyeloid cells,
GMPs and committed neutrophils and their precursors, respectively. The expression of cebpa
with these additional markers mirrors the importance of C/EBPα in the mammalian system
in which C/EBPα is important for committment to a myeloid lineage versus an erythroid lin‐
eage, to a granulocyte lineage over a macrophage lineage, and in terminal differentiation of
neutrophils. An orthologue of cebpa was also identified in Japanese flounder and mRNA
was observed in the head and posterior kidney, spleen, liver, gill, heart, brain, skin, intraper‐
itoneal cells, and weakly in the intestine, muscle and PBLs [171]. However, expression of
cebpa in isolated cells populations was not performed.
Two studies have examined the function of CEBPα in zebrafish primitive myelopoiesis. The
injection of a deletion mutant of cebpa into zebrafish embryos functioned as a dominant-neg‐
ative mutation and blocked the production of full-length CEBPα. These embryos exhibited
an increase in gata1+ expression in the posterior lateral plate mesoderm at 22 hpf and in the
intermediate cell mass at 26 hpf, reflective of an erythroid progenitor cell expansion. This
expression corresponded to a subsequent increase in circulating erythrocytes based on the
increase in α-hemoglobin expression, indicative of erythrocytes [182]. However, the expres‐
sions of the myeloid specific genes, mpo and l-plastin, were normal [182]. Based on the pat‐
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tern of expression, it was suggested that PU.1 acts upstream or in parallel with C/EBPα
during zebrafish primitive myelopoiesis [182]. Recently, it has been shown that the sumoy‐
lation (a post-translational protein modification) of zebrafish CEBPα inhibited CEBPα tran‐
scriptional activity and its ability to interact with and repress GATA1, thus driving lineage
commitment of a myelo-erythroid progenitor to that of the erythroid lineage [183]. Taken to‐
gether, these studies demonstrate the conserved role of CEBPα in the commitment of a CMP
to a GMP. However, due to the toxicity of cebpa morpholinos to zebrafish embryos, knock‐
down experiments could not be performed.
Cebpb was identified in rainbow trout as a single intron-less gene and the predicted CEBPβ
protein showed 30-34% amino acid identity to mammalian C/EBPβ [169]. The cebpb mRNA
was detected in the head and posterior kidney, spleen, liver, gill, intestine, muscle and pe‐
ripheral blood leukocytes (PBLs) [169]. Japanese flounder CEBPβ also showed a low
(33-38%) amino acid identity to other vertebrate sequences, but retained 95% amino acid
identity in the bZIP domain. The cebpb mRNA was expressed in the head and posterior kid‐
ney, liver, gill, brain, peritoneal cavity fluid and PBLs, with low mRNA levels in the heart,
intestine, mucus, eye and spleen [170]. In zebrafish, CEBPβ showed 49% amino acid identity
to human C/EBPβ and cebpb mRNA was detected in cells on the surface of the yolk sac, cor‐
responding to the myeloid cells that normally spread over the yolk sac early in embryogene‐
sis [168]. A cebpb transcript was also identified in a differential cross-screen of goldfish
proliferative phase and senescence phase PKMs, and was up-regulated in goldfish mono‐
cytes, and expressed in low levels in progenitors and macrophages [19]. However, the func‐
tional role of CEBPβ has not been examined in teleost myelopoiesis.
The orthologues of C/EBPδ, C/EBPγ and C/EBPε exist in teleosts. The cebpd and cebpg tran‐
scripts were identified in zebrafish and show a ubiquitous expression pattern in embryos
[168]. CEBPδ and CEBPγ showed 57 and 50% identity to their human counterparts on the
amino acid level. However, their bZIP domains showed higher conservation to their human
counterparts, with 86% and 76% amino acid identity, respectively [168]. The cebpe ortho‐
logue was identified in Japanese flounder and its corresponding predicted protein had a
27% overall amino acid identity and a 90% amino acid identity in the bZIP domain com‐
pared to the mammalian counterparts, but failed to cluster with other cebpe sequences in
phylogenetic analysis [170]. The cebpe mRNA was detected in the head and posterior kidney,
spleen, brain, peritoneal cavity fluid and at low levels in the PBLs. However, the functional
role of these C/EBPs in teleost myelopoiesis is unknown.
4.3.3. PU.1
The Ets transcription family member PU.1 is well known as the master transcriptional regu‐
lator of mammalian myelopoiesis through an antagonistic relationship with GATA1, recent‐
ly reviewed by [184]. At the N-terminus, PU.1 comprises of an acidic domain and a
glutamine rich domain that are involved in activation of transcription, and a PEST domain
important for protein interactions [184]. At the C-terminus, PU.1 has an Ets domain impor‐
tant for binding the DNA consensus sequence AAAG(A/C/G)GGAAG [185]. Mice deficient
in PU.1 (PU.1-/-) have reduced CLPs, and GMPs, increased numbers of MEPs, and lack B-
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cells, T-cells, monocytes/macrophages as well as severely reduced numbers of granulocytes
[186-190]. PU.1 is expressed in HSCs, CLPs and at varying levels in CMPs, increasing as
these progenitors are induced to differentiate into monocytes/macrophages and neutrophils
[191]. At the CMP stage, PU.1 antagonizes with GATA1 to determine whether the CMP
commits to a GMP or a MEP. PU.1 binds to GATA1 and inhibits GATA1 from binding to
and initiating transcriptional activation of a number of erythroid genes that are important
for commitment to an erythroid lineage [184, 192, 193]. The reverse is also true; GATA1 can
bind to PU.1 and inhibit the binding of PU.1 and transcriptional activation of a number of
myeloid genes [184, 192, 193], including to the promoters of CSF-1R [194-196] and GCSFR
genes [181, 196, 197]. Therefore, the lineage fate decision along a GMP or a MEP fate is a
balancing act in timing and relative protein levels of PU.1 and GATA1.
PU.1 also plays a role at the GMP stage to regulate commitment to a granulocyte or mac‐
rophage lineage. Increased levels of PU.1 at the GMP stage, along with AP-1 association,
drives a monocyte cell  fate,  while lower levels of PU.1 drives granulocyte cell  fate [175,
177].  Furthermore,  PU.1  induces  EGR-2  and NAB-2  expression  [177].  The  EGR-2/NAB-2
transcription  factors  function  to  repress  neutrophil  genes  by  antagonizing  GFI1,  an  im‐
portant transcription factor in the initiation of  neutrophil  differentiation [177],  discussed
in section 5.3.2.
An orthologue of PU.1 has been identified in teleosts. In the Japanese flounder, pu.1 mRNA
was detected in the head and posterior kidney, spleen, heart, PBLs, intraperitoneal cells, and
weakly in the intestine and gill, but was absent from the liver, skin, muscle and brain [171].
In zebrafish, pu.1 was identified as a single gene copy and analysis of the predicted protein
sequence showed the conserved transactivation, PEST, and DNA-binding domains. Al‐
though the overall amino acid identity to other PU.1 proteins was 48-53%, the DNA-binding
domain of zebrafish PU.1 showed 83% amino acid identity to mammalian PU.1 [198]. Ex‐
amination of the zebrafish pu.1 promoter region predicted potential binding sites for PU.1
and CEBPα [199]. The expression of pu.1 is first detected at 12 hpf in blood cells from the
PLM, later in the ICM, and finally in the kidney, and these pu.1+ blood cells give rise to mye‐
loid cells [198-200]. The population of pu.1+ cells represents myeloid HPCs, myeloid precur‐
sors, monocytes/macrophages and neutrophils during both primitive and definitive
myelopoiesis in the zebrafish [24, 200].
Knockdown of pu.1 in zebrafish using morpholinos showed a large reduction in the number
of cells positive for mpo and l-plastin mRNA, markers of granulocytes and monocytes/macro‐
phages [201, 202]. In addition to the loss of myeloid cells, an increase in gata1 expression was
observed, and these gata1+ cells gave rise to mature erythrocytes [201]. Conversely, gata1
morphants failed to develop mature erythrocytes and showed an increase in the number of
pu.1+, mpo+ and l-plastin+ cells [201, 202]. Ectopic expression of pu.1 or gata1 was observed in
gata1 or pu.1 morphants, respectively, suggesting the conversion of progenitors to an alter‐
nate lineage [201, 202]. Microarray analysis of genes regulated by PU.1 revealed the regula‐
tion of ~250 genes, including cebpa, csf-1r and myeloid-specific peroxidase (mpx), among
others [203]. Taken together, PU.1 has a conserved role in dictating a myeloid lineage, op‐
posing GATA1 and the transcriptional activation of erythroid genes.
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A pu.1-like gene (spi-1 like, spi-1l) was also identified in zebrafish. The predicted amino
acid sequence of SPI-1l showed 45% amino acid identity to zebrafish PU.1, and retained
all three domains [204]. In situ hybridization revealed a population of blood cells positive
for pu.1 and spi-1l,  in addition to a population of single positive pu.1 cells [204]. Howev‐
er,  only a few single-positive spi-1l  cells were observed. Spi-1l  morphants showed a loss
of  mpx  and  l-plastin  positive  cells,  indicative  of  a  loss  in  granulocytes  and  monocytes/
macrophages [204]. Unlike pu.1  morphants, no change in gata1  expression was observed,
suggesting that SPI-1l acts downstream of PU.1, and plays an important role in myeloid
cell differentiation [204].
5. Commitment of bi-potent myeloid progenitors to the macrophage or
neutrophil lineage
5.1. Macrophage development
5.1.1. Progression of cell development
In  mammalian  systems,  the  progression  of  macrophage  development  proceeds  from  a
committed  macrophage  progenitor,  monoblast,  promonocyte,  monocyte  and  then  to  a
mature tissue macrophage, reviewed by [205-207] (Figure 1). While the presence of a uni‐
potent  committed  macrophage  progenitor  has  yet  to  be  unequivocally  demonstrated  in
the  teleost  systems,  progenitor/precursor  cells  that  give  rise  to  monocytes  and  macro‐
phages  have  been  demonstrated.  In  vitro,  a  spontaneous  proliferating  trout  RTS-11  cell
line has two predominant cell types; a round non-adherent cell type that appears to be a
pre-monocyte  or  myeloid  precursor  and an adherent  macrophage-like  cell,  arising  from
the non-adherent cell type [208].  The cultivation of trout kidney progenitor-like cells de‐
veloped a trout primary kidney monocyte culture that contained progenitor cells,  prom‐
onocyte-like cells,  and monocytes [209].  Furthermore, the generation of goldfish primary
kidney  macrophage  cultures  demonstrated  that  small  mononuclear  cells  became  mono‐
cytes  and  mature  macrophages,  in  vitro.  In  the  zebrafish  model  system,  whole  kidney
marrow was added to a  kidney fibroblast  layer  and was shown to maintain HPCs and
precursor  cells  that  then differentiated into myeloid and lymphoid cells  [210].  Recently,
the development of a zebrafish methylcellulose colony forming unit assay suggested the
presence of a common erythro-myeloid HPC [211]. In vivo studies, primarily in the zebra‐
fish,  have  demonstrated  that  monocytes/  macrophages  arise  from the  hematopoietic  or‐
gan  [45,  212-215],  migrate  to  various  tissues  [216],  and  both  primitive  and  definitive
macrophages  are  motile,  migrate  to  the  site  of  insult,  and readily  phagocytose  particles
or  pathogens  [23,  45,  217-219].  The  identification of  progenitor  cells  that  are  capable  of
differentiating into monocytes and macrophages suggests a conserved macrophage differ‐
entiation pathway in vertebrates.
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5.1.2. Receptors and growth factors
5.1.2.1. Colony-stimulating factor-1
The central growth factor that regulates the survival, proliferation, and differentiation of
macrophages and their precursors is colony-stimulating factor-1 (CSF-1) [220-223]. Alterna‐
tive splicing of CSF-1 transcripts leads to production of a secreted glycoprotein, a secreted
proteoglycan, or a membrane-bound glycoprotein that can be proteolytically cleaved from
the surface, reviewed by [144, 221]. However, only the first 149-150 aa of the N-terminal por‐
tion of the CSF-1 core protein has shown to be important for biological function [224, 225].
CSF-1 homodimers, are covalently linked by an interchain disulphide bond to form a dimer
[226] that then binds the CSF-1 receptor. CSF-1 is produced by an array of cell types includ‐
ing fibroblasts, endothelial cells, and bone marrow stromal cells, reviewed by [144]. In addi‐
tion, activated T-cells [227-229], monocytes, macrophages [230, 231], fibroblasts, and
endothelial cells [144] can produce CSF-1. CSF-1 production by activated cell types suggests
a role for CSF-1 at the site of inflammation, which may be necessary for the rapid recruit‐
ment, differentiation and activation of macrophages and their precursors.
5.1.2.2. Interleukin-34
Recently, IL-34 was identified as another growth factor involved in mediating macrophage
development in mammals, in addition to CSF-1 [232-234]. The IL-34 protein does not show
homology to any other human protein and or contain any known conserved structural mo‐
tifs [232]. Homodimeric IL-34 binds to CSF-1R, although with a different affinity than that of
CSF-1, and to different sites on the receptor [232, 233] [235]. The hierarchy in binding of the
CSF-1R ligands may provide a mechanism for differential signaling depending on the
bound ligand. To date, IL-34 has not been identified in teleosts.
5.1.2.3. Colony-stimulating factor-1 receptor
The CSF-1R gene, shown to map to the proto-oncogene c-fms, is a member of the type III ty‐
rosine kinase family of receptors [236, 237], reviewed by [238]. The binding of homodimeric
CSF-1 to CSF-1R, triggers receptor homodimerization and activation [239]. Receptor activa‐
tion triggers autophosphorylation of the intracellular tyrosine residues and activation of
JAK/STAT, PI3K/Akt, and MAPK pathways, as well as pathways for receptor-mediated in‐
ternalization and destruction, reviewed by [162, 238, 240]. Within the hematopoietic system,
CSF-1R protein is primarily found on macrophages and their precursors and has been used
as a marker of cells along the macrophage lineage in mammalian systems [222, 237]. CSF-1R
progressively increased with macrophage differentiation [144].
5.1.2.4. Biological functions of colony stimulating factor-1
In addition to the regulation of survival, proliferation, and differentiation of macrophages
and their precursors [220-223], CSF-1 has been shown to exert pro-inflammatory effects on
monocytes and macrophages. These effects include the enhancement of macrophage chemo‐
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taxis, phagocytosis of pathogens, and the production of antimicrobial agents, reviewed by
[162, 238]. CSF-1 is a pleiotropic cytokine and functions in a number of other biological sys‐
tems such as regulation of macrophage and osteoclast numbers, bone remodeling, tooth pro‐
duction and fertility and breast development [241-245]
5.1.2.5. Teleost colony stimulating factor-1
Teleost csf-1  (mcsf)  was first identified in the goldfish as a 600 bp mRNA transcript that
was present at high levels in spleen tissue, monocytes, and phorbol ester-activated mono‐
cytes [246].  The csf-1  transcript encoded for a 199 aa precursor protein, with the mature
CSF-1 protein predicted to  have a  molecular  weight  of  22  kDa.  The goldfish CSF-1 has
27%  aa  identity  to  human  CSF-1  [246].  Alignment  of  goldfish  CSF-1  with  mammalian
CSF-1s showed conservation of four cysteine residues required for protein folding, simi‐
lar to that of mammalian CSF-1 [246]. Ligand-receptor binding studies demonstrated that
homodimeric CSF-1 could bind to soluble CSF-1R (see teleost CSF-1R section below, Fig‐
ure 1). Functional characterization of a recombinant goldfish CSF-1 was shown to induce
monocyte  proliferation and differentiation (Figure  1),  which was  abrogated in  the  pres‐
ence of sCSF-1R or in monocytes transfected with csf-1r RNAi oligos [246, 247]. Recombi‐
nant goldfish CSF-1 also aided in the long-term survival of mature macrophages in vitro
[247]. The recombinant CSF-1 protein was chemoattractive to PKMs, and promoted their
ability  to  perform phagocytosis  and produce antimicrobial  compounds [248],  suggesting
a pro-inflammatory role for CSF-1 in goldfish.
Two csf-1 genes were later identified in trout and zebrafish, termed mcsf-1 and mcsf-2, and a
second goldfish mcsf transcript was identified [249]. The trout and zebrafish mcsf-1 genes en‐
coded for proteins of 593 and 526 aa, the trout and zebrafish mcsf-2 genes encoded for pro‐
teins of 276 and 284 aa, respectively, while the goldfish mcsf gene encoded for a 544 aa
protein [249]. All of the identified transcripts possessed a signal peptide, a CSF-1 domain, a
transmembrane domain, and a short cytoplasmic domain [249]. However, the N-terminal re‐
gion of all teleost CSF-1 proteins showed high homology (46-88%), consistent with the im‐
portant role of the CSF-1 N-terminal portion for biological function.
The  genomic  structure  of  the  identified  mcsfs  also  differed.  The  zebrafish  mcsf-1,  found
on  chromosome  11,  possessed  seven  exons  and  mcsf-2,  found  on  chromosome  8,  pos‐
sessed nine exons. Based on syntenic analysis, the two mcsf genes appeared to have arose
through  a  chromosomal  or  genome  duplication  [249].  Examination  of  the  intron-exon
structure of  trout  mcsfs  showed mcsf-1  to  possess  10 exons and 9 introns,  and mcsf-2  to
have 9 exons and 8 introns [249].
Along with differing genomic organizations, trout mcsf-1/-2 are differentially expressed in
tissues. The mcsf-1 transcript was predominantly expressed in the spleen, intestine and
brain, while mcsf-2 was predominantly expressed in the head kidney, gills, muscle and liver
[249]. While a recombinant trout MCSF-1 protein was produced and demonstrated to induce
the proliferation of head kidney macrophages, a recombinant trout MCSF-2 protein was not
produced to examine whether there was differential regulation of macrophage function by
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the MCSFs [249]. Whether MCSF-1 and MCSF-2 are functionally redundant or functionally
partitioned (sub-functionalization), remains to be determined.
5.1.2.6. Teleost colony-stimulating factor-1 receptor
The csf-1r sequences have been identified in a number of teleost species including puffer fish
[250, 251], zebrafish [252], rainbow trout [253], gilthead seabream [254] and goldfish [20].
CSF-1R protein appears to be a marker of monocytes and macrophages in teleosts [20, 254,
255] (Figure 1). Analysis of the puffer fish csf-1r gene shows a 21 exon gene structure in fish,
same as in mammals. However, the puffer fish csf-1r gene only spans 10.5 kbp versus the
mammalian 55 kbp, due to the decrease in the size of the intronic sequences [250]. The csf-1r
mRNA open reading frame encodes for a 975 aa protein, with a signal peptide, an extracel‐
lular domain with 10 conserved cysteine residues characteristic of immunoglobulin do‐
mains, transmembrane domain, and an intracellular kinase domain with an interruption of
70 bp [250]. While CSF-1R of puffer fish is only 39% similar to human CSF-1R, the kinase
domain is considerably more conserved, particularly in the motifs associated with signaling.
The fish csf-1r gene was linked with pdgfrb-1 [250].
A second csf-1r gene (csf-1r-2) was also identified in puffer fish, and linked with a second
pdgfrb (pdgfrb-2). The csf-1r-2 gene was comprised of 22 exons and had a different intron-
exon organization than csf-1r-1 [251]. Despite the similar protein structure of the two
CSF-1Rs, the amino acid sequences were only 39% identical. The csf-1r mRNAs were differ‐
entially expressed in tissues. The csf-1r-1 was expressed in blood, brain, eye, gill, heart, kid‐
ney, ovary, skin, and spleen, while csf-1r-2 was expressed in the blood, brain, eye, gill, heart,
kidney, liver, muscle, skin, spleen and testis. [251].
The duplication of csf-1r genes was also observed in cichlids, the green-spotted pufferfish,
medaka, and Tetraodon (found on chromosomes 1 and 7), with the csf-1r-2 duplicated genes
appearing to have undergone evolutionary selection or diversification while the csf-1r-1
gene appeared to resemble that of the ancestral gene [256]. It was proposed that the fish spe‐
cific whole genome duplication generated the two paralogues of csf-1r in fish, as well as two
pdgfrb and kit genes, and that kit and csf-1r-2 may have been retained to play a role in the
survival, migration and differentiation of melanocytes and xanthophores, important pig‐
ment cells involved in fish coloration patterns [256].
The panther (fms) mutant zebrafish have a defect in the csf-1r gene, and mutant fish fail to
develop their characteristic pigment pattern of black and yellow stripes. The CSF-1R was
found to be important in the survival, migration and differentiation of precursors to yellow
xanthophores in zebrafish [257, 258]. However, unlike that of the CSF-1R-/- mice, there were
no reports of hematopoietic defects in panther zebrafish. The lack of hematopoietic defects
may be due to the presence of another csf-1r gene, a low level of csf-1r expression, or a differ‐
ential requirement for CSF-1R during embryonic macrophage development versus adult
macrophage development in teleosts. However, CSF-1R was shown to be important in the
migration of primitive macrophages to tissues, such as the brain, retina and epidermis upon
comparing primitive macrophage distribution and migration in wild-type and panther ze‐
brafish [252]. Furthermore, csf-1r mRNA was detected in inflammatory macrophages from 3
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dpf zebrafish embryos [219]. Taken together, these results support a role for CSF-1R in tele‐
ost macrophage biology.
A full-length csf-1r cDNA sequence was identified in trout, with an open reading frame of
2904 bp encoding for a 967 aa protein, predicted to be ~109 kDa. Trout CSF-1R had 40% aa
identity to that of human and mouse, and 54% and 52% identity to that of puffer fish and
zebrafish CSF-1R [253]. The trout csf-1r gene was similar to that of the ancestral gene, and
mRNA was found in the head-kidney, spleen, blood, ovary, and showed lower mRNA lev‐
els in the liver, brain, heart, muscle, gill, and skin [253]. Southern blotting revealed two
bands in each lane, suggestive of a second csf-1r gene in trout. However, a second csf-1r gene
was never identified.
CSF-1R was also identified in goldfish as a 975 aa integral membrane bound protein
(mCSF-1R) that possessed the five Ig extracellular domains with multiple N-linked glycosy‐
lation sites, a transmembrane domain, and an intracellular tyrosine kinase domain [20]. The
mRNA of mCSF-1R could be detected in progenitor, monocyte and macrophage subpopula‐
tions, and an antibody produced against the first two Ig domains of CSF-1R was able to rec‐
ognize monocytes and macrophages [20]. However, unlike mammalian neutrophils,
zebrafish and goldfish neutrophils do not appear to express mRNA for csf-1r [16, 219]. Addi‐
tionally, alternative splicing of the csf-1r transcript encoded for a soluble form of the CSF-1R
(sCSF-1R), possessing only the D1 and D2 Ig domains, important for binding of CSF-1. The
scsf-1r mRNA was expressed by leukocytes within the progenitor and macrophage popula‐
tions, but not in the monocyte subpopulation [20]. Furthermore, addition of a recombinant
purified sCSF-1R dampened the proliferation of spontaneously growing and differentiating
PKMs [20]. The increased production of the sCSF-1R by PKMs during senescence phase sug‐
gested that sCSF-1R was involved in the negative regulation of CSF-1 signaling through
mCSF-1R [20, 246] (Figure 1).
5.2. Neutrophil development
5.2.1. Progression of cell development
Following the commitment of the CFU-GM to a committed granulocyte progenitor cell, ter‐
minal differentiation through a promyelocyte, myelocyte, and metamyelocyte stages occur
to give rise to a mature neutrophil, and are regulated through growth factor and transcrip‐
tion factor signaling, reviewed by [259] (Figure 1). Similar to that of mammals, the differen‐
tiation of fish neutrophils appears to occur through various stages, based on morphological
and cytochemical characteristics, and include the promyelocyte, myelocyte, metamyelocyte
and the mature neutrophil, which sometimes had a segmented nucleus [45, 212, 213, 215,
260]. These neutrophils were shown to migrate from the hematopoietic organ to the site of
wounding, pathogen injection, or transformed cell injection [24, 45, 261], in response to a hy‐
drogen peroxide attractant produced by cells at the site of damage [217]. However, the re‐
sponding neutrophils had low phagocytic activity [24], or engulfed small fragments of the
pathogen [217]. In vitro, treatment of zebrafish kidney marrow cells with G-CSF gave rise to
CFU-GM in a methylcellulose assay [211]. However, there is a lack of in vitro culture sys‐
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tems for studying progenitor cell to neutrophil differentiation. The identification of func‐
tional neutrophils and their precursors suggests the presence of a committed granulocyte
progenitor cell in teleosts.
5.2.2. Receptors and growth factors
5.2.2.1. Granulocyte colony-stimulating factor
Neutrophils contribute to both innate and adaptive immune responses. They are capable of
chemotaxis, phagocytosis, antimicrobial molecule production, and formation of extracellular
traps [262-267]. Upon activation, neutrophils produce a number of chemokines, pro-inflam‐
matory and anti-inflammatory cytokines, as well as the colony-stimulating factors G-CSF,
CSF-1, GM-CSF, IL3 and SCF, reviewed by [268, 269]. However, neutrophils are short lived,
6-90 hrs, and need to be continuously replaced.
GCSF, a member of the class I cytokine family, is the primary CSF that mediates the prolifer‐
ation, differentiation, survival and activation of neutrophils and their progenitors, and has
been reviewed extensively by [144, 270]. The transcription of GCSF is controlled by an up‐
stream promoter region with a tumor necrosis factor alpha response region that is bound by
NF-kB p65 and NF-IL6, reviewed elsewhere by [144, 271]. As such, GCSF can be produced
by activated monocytes/macrophages, neutrophils, fibroblasts and endothelial cells in re‐
sponse to a number of pro-inflammatory stimuli, reviewed elsewhere by [144, 270, 271]. In
humans, the normal GCSF concentration in blood ranges from 30-162 pg/mL, and can be
massively up-regulated during infection up to 3200 pg/mL [272-274].
5.2.2.2. Granulocyte colony-stimulating factor receptor
The protein structure of GCSFR is comprised of a signal peptide, an immunoglobulin-like
domain, a cytokine receptor homology (CRH) domain containing the class I cytokine recep‐
tor superfamily motif W-S-X-W-S, three fibronectin domains, a transmembrane domain, and
an intracellular cytoplasmic signaling domain containing three motifs termed Box 1, Box 2,
and Box 3, important for signal transduction [270, 275]. Based on their protein structure and
conserved motifs, the human and mouse integral membrane GCSFR proteins were placed in
the type I cytokine receptor family.
While there are reports of GCSFR on other hematopoietic cells such as monocytes [276] and
lymphocytes, as well as some non-hematopoietic cells, GCSFR is primarily found on neutro‐
phils and their precursors [270, 277]. Neutrophils up-regulate their levels of GCSFR as they
differentiate from progenitor cell to mature neutrophil, with 50-500 GCSF receptors per cell
[278]. Structural analysis showed GCSF forms a homodimer, binds two GCSFRs, and leads
to receptor homodimerization in a 2:2 complex [279-281]. Binding of a homodimeric GCSF
to two GCSF receptors triggers intracellular signaling through the JAK/STAT, Ras/Raf/Erk,
or PI3K pathways [275, 277, 282]. These signaling pathways ultimately lead to the migration,
survival, proliferation, and differentiation of neutrophils. Control of GCSFR signaling in
neutrophils is modulated through (1) transcriptional activation of the GCSFR by AP-1, AP-2,
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C/EBPα, NF-IL6, GATA-1, and PU.1/SPI1 transcription factors [181, 197], (2) the production
of a soluble receptor through alternative splicing [275], and (3) cleavage of surface GCSFR
by elastase [283].
5.2.2.3. Biological activity of granulocyte colony stimulating factor
The targeted gene disruption of GCSF  and GCSFR has demonstrated the important func‐
tional roles of GCSF in vivo. GCSF and GCSFR deficient mice display severe neutropenia
(70%-88% reduction  in  circulating  neutrophils),  reduction  in  monocyte  and macrophage
numbers,  and  ~50%  reduction  in  the  numbers  of  neutrophil  precursors  present  in  the
bone marrow [284,  285] [282,  286] and are unable to control Listeria monocytogenes  infec‐
tions [284,  285].  GCSF treatment of bone marrow cells,  in vitro,  induced CFU activity to
produce  mainly  neutrophil  colonies  [287]  and  promoted  the  proliferation  of  neutrophil
precursors [270]. The release of mature neutrophils, their terminal differentiation, surviv‐
al, and activation, is also mediated by GCSF in vitro and in vivo, reviewed by [270]. Last‐
ly,  GCSF  has  been  used  in  the  clinical  setting  to  increase  peripheral  blood  neutrophil
numbers for  treatment of  disease and for  stem cell  mobilization from the bone marrow
into the peripheral blood, reviewed by [288, 289].
5.2.2.4. Teleost granulocyte colony-stimulating factor
The teleost gcsf gene was first identified in Japanese flounder, fugu, and the green-spotted
pufferfish [290]. Both the fugu and green-spotted pufferfish have two gcsf genes, termed
gcsf-1 and gcsf-2, while only an orthologue of gcsf-2 was identified in flounder [290]. Phylo‐
genetic analysis of vertebrate gcsfs predicted fish gcsf-1 to be the ancestral gene, while gcsf-2
was predicted to be the duplicated gene. Alignment of the fish GCSFs with human and
mouse GCSF showed low identity, ranging from no significant identity to 34% amino acid
identity [290]. Despite the low amino acid identity of fish to mammalian GCSF, all fish gcsf
genes retained a 5 exon/ 4 intron structure with a conserved tumor necrosis factor alpha re‐
sponse element in the promoter region. Furthermore, the predicted transcripts have an open
reading frame of 561-636 bp, corresponding to a predicted protein of 20-23 kDa, and 4-5 AU
rich sequences in their 3’ UTRs shown to be involved in mRNA instability and degradation
[290]. Determination of the ratio of synonymous to asynonymous nucleotide substitutions
(Ks/Ka) in fish gcsf genes ranged from 0.467 to 0.961 with an average of 0.793, demonstrating
that positive selection was occurring in GCSFs of fish (and chicken) [290]. Two gcsf genes
were also identified in the black rockfish (Sebastes schlegelii) [291] and in zebrafish [292] (O.
Svoboda and P. Bartunek, personal communication), while only one gcsf gene has been iden‐
tified in trout (NM_001195184).
Flounder gcsf-2 mRNA levels were highest in the spleen, kidney, and gill. However, gcsf-2
mRNA was still detected in the brain, eyes, heart, peripheral blood leukocytes, ovary, skin,
and stomach, but was not detected in intestine, liver, or muscle tissue [290]. As expected,
gcsf-2 mRNA levels were up-regulated in kidney and peripheral blood leukocytes following
treatment with lipopolysaccharide (LPS) or a mixture of concanavalin A and phorbol esters
(ConA/PMA) [290]. The black rockfish gcsf-1 showed expression in the peripheral blood leu‐
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kocytes, spleen, gill, intestine and muscle [291]. However, black rockfish gcsf-2 was ubiqui‐
tously expressed in the peripheral blood leukocytes, head and trunk kidney, spleen, gill,
intestine, muscle, liver and brain [291]. Although both gcsf-1 and gcsf-2 black rockfish
mRNA levels were upregulated in PBLs treated with LPS or ConA/PMA, differential kinet‐
ics and levels of expression were observed between the two gcsfs [291]. It appears that gcsf-1
may be rapidly induced with sustained levels following stimulation, whereas gcsf-2 is only
slightly upregulated and showed a drastic increase in mRNA levels after ConA/PMA treat‐
ment for 24 hrs [291]. Taken together, these data suggest that GCSF-1 may play an important
role during inflammation, although functional studies are required to determine the roles of
GCSF-1 and GCSF-2 in teleost granulopoiesis and inflammation.
Functional studies on fish GCSF-1 are limited. Only two manuscripts report on the func‐
tion of GCSF-1 and both utilize the zebrafish model system. In vitro, precursor cells from
whole kidney marrow were sorted, plated in a methylcellulose colony forming unit assay
and treated with either GCSF or a combination of GCSF and erythropoietin (EPO). While
both treatments led to CFUs containing granulocytes and macrophages, the combination
of  GCSF and EPO also  supported the  formation of  erythroid  CFUs [211].  In  vivo,  mor‐
pholino  mediated  knockdown  of  gcsfr  in  zebrafish  showed a  decrease  in  numbers  and
migration of cells expressing both neutrophil and macrophage specific transcripts, during
both primitive and definitive hematopoiesis in the zebrafish embryo. However, a popula‐
tion  of  myeloid  cells  remained,  despite  morpholino  mediated  knockdown of  gcsfr,  sug‐
gesting the presence of a GCSFR-independent pathway of myeloid cell development and
migration [292].  Injection of  wild-type zebrafish  with  gcsf  mRNA increased the  number
of myeloid and gcsfr+  cells, while injection of gcsf  mRNA into gcsfr  morpholino zebrafish
did  not  result  in  an  increase  in  myeloid  cell  numbers  [292].  These  studies  suggested
GCSF-1 participates in myeloid cell development, similar to that observed in mammalian
systems  (Figure  1).  No  functional  studies  have  been  performed using  GCSF-2,  and  the
role(s) of GCSF-2 in myelopoiesis remain to be elucidated.
5.2.2.5. Teleost granulocyte colony-stimulating factor receptor
The gcsfr has been identified in zebrafish [292], goldfish [293], and trout (AJ616901). Only
one gene copy has been identified, although Southern blotting for goldfish gcsfr suggested
the presence of more than one gene [293]. Analysis of the upstream promoter region of the
16 exon zebrafish gcsfr gene showed conserved putative sites for binding of the transcription
factors HOXA5, PU.1 and CEBP family members [292], similar to the human gcsfr promoter
region. These data suggest the conserved regulation of gcsfr gene expression in teleosts.
The  predicted  protein  structure  of  zebrafish  and  goldfish  GCSFRs  is  conserved  across
vertebrates. The teleost GCSFR extracellular domain is comprised of a signal peptide, an
Ig-like domain, a cytokine homology domain containing the WSXWS motif and four cys‐
teine residues,  and three fibronectin domains.  Following the transmembrane region,  the
intracellular region contains predicted Box1, Box2, and Box 3 signaling motifs and 6 tyro‐
sine residues [292,  293],  shown to be involved in receptor activation and internalization
in higher vertebrates.
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In zebrafish, gcsfr mRNA is expressed by 14 hpf in the RBI, followed by the yolk sac, the
ICM, and finally in the kidney by 96 hpf, consistent with the production of neutrophils dur‐
ing primitive and definitive hematopoiesis. In adult goldfish, gcsfr mRNA levels were high‐
est in kidney and spleen, followed by the gill, intestine, heart, brain and blood [293]. The
gcsfr mRNA was highly expressed in goldfish neutrophils and was up-regulated in response
to mitogens or pathogens [293] (Figure 1).
5.3. Transcription factors
In  addition  to  the  transcription  factors  described  in  section  4.3,  there  are  a  number  of
transcription factors downstream that participate in determining GMP fate decisions and
that play a role in macrophage and neutrophil  cell  development,  reviewed by [51,  294].
A visual representation of the stage(s) in which these transcription factors are important
are shown in Figure 2.
5.3.1. Early growth response (Egr)
The  four  Egr  proteins,  EGR1  [295,  296],  EGR2  [297],  EGR3  [298]  and  EGR4  [299],  are
members of the zinc finger transcription factor family and have an N-terminus activation
domain, a repressor domain capable of binding to NAB1/2, and a DNA binding domain
comprised  of  three  zinc  fingers  that  bind  to  the  GC  rich  sequence,  5’-GCGGGGGC’3’
[300]. EGR1 promotes commitment to the macrophage lineage at the expense of granulo‐
cytic lineage [301, 302] and has been shown to be essential for myeloblast differentiation
into  monocytes/macrophages  [303,  304].  Treatment  of  mouse  bone  marrow  cells  with
CSF-1 has been shown to induce EGR1  mRNA levels by 6-7 fold three hours post treat‐
ment,  as well  as EGR2  and EGR3  mRNA levels  by 2-4 fold [305].  Although EGR-/-  mice
display  normal  macrophage  development  [306],  it  is  thought  that  there  is  redundancy
amongst  the Egr transcription factors.  Consistent  with this  idea,  EGR2 is  also abundant
in  monoblasts  and  monocytes  [307],  and  may  be  involved  in  monocyte  differentiation.
Although a zebrafish orthologue of EGR1 has been identified [308], the role of egr1 in tel‐
eost macrophage development has not been examined.
5.3.2. Growth factor independence 1 (Gfi1)
Growth factor independence 1 (GFI1) is a zinc finger transcription factor comprised of an N-
terminal Snail/Gfi1 (SNAG) domain that is involved in recruiting proteins to modify histo‐
nes, and a C-terminal domain containing six zinc fingers involved in DNA recognition [309].
GFI1 is expressed in T-cells, B-cells, mature granulocytes and activated macrophages [310,
311]. GFI1-/- mice showed slight defects in lymphocyte development, increased monocyte
and monocyte precursor numbers, an absence of granulocytes and were highly susceptible
to infections [310, 311]. Furthermore, myeloid progenitors from GFI1-/- mice did not differen‐
tiate into mature granulocytes in the presence of GCSF in vitro [310] or in vivo [311]. C/EBPα
can up-regulate GFI1 expression, promoting a neutrophil cell fate, and GFI1 also acts as a
negative regulator on PU.1 to decrease its expression [177, 180]. This lower level of PU.1
drives granulocyte cell fate [175, 177]. GFI1 is important for neutrophil differentiation [177,
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310, 312] and acts by activating Ras guanine nucleotide releasing protein 1 (RasGRP1) which
is necessary for activating Ras in the Ras/MEK/Erk pathway that is initiated during GCSF
signaling [313]. The expression of GFI1 is sustained during differentiation and the transcrip‐
tion factor functions by blocking the expression of EGR-2/NAB-2, effectively antagonizing
the EGR1/2 transcription factor and preventing initiation of a monocytic differentiation
pathway, thereby promoting neutrophil differentiation [177, 312]. Like that of PU.1 and GA‐
TA1, GFI1 and EGR-1/EGR-2 act as an antagonistic pair to regulate neutrophil versus macro‐
phage lineage fate.
In zebrafish, two gfi1 genes have been identified, termed gfi1 and gfi1.1. gfi1 is primarily ex‐
pressed in neural tissues, and not in the hematopoietic system [314], suggesting that this is
not the functional orthologue of mammalian GFI1. However, gfi1.1 was expressed in the dif‐
ferent hematopoietic organs of the developing zebrafish embryo, suggesting that gfi1.1 is ex‐
pressed in hematopoietic cells [315]. Zebrafish gfi1.1 morphants displayed a three-fold
increase in the number of pu.1+ cells, along with an increase in l-plastin expression and a de‐
crease in mpo expression [315]. These data are consistent with the known functional role of
mammalian GFI1, suggesting that zebrafish GFI1.1, and not zebrafish GFI1, is the functional
orthologue of mammalian GFI.
5.3.3. Interferon response factor-8 (IRF-8)
Interferon response factor-8 (IRF-8, also known as ICSBP) is one out of nine members of the
IRF transcription factor family and is characterized by an N-terminal DNA binding domain
and a C-terminus IRF association domain that can associate with other IRF or Ets transcrip‐
tion family members [316, 317]. IRF8-/- mice and BXH-2 mice with a mutation in their IRF
association domain show a drastic expansion of granulocytes at the expense of macrophages
[318, 319]. Enforced expression of IRF8 in myeloid progenitor cells in vitro led to the induced
expression of a number of macrophage lineage differentiation transcripts including CSF-1R
and EGR1. Additionally, enforced expression of IRF8 in myeloid cell lines prevented their
differentiation into granulocytes when treated with GCSF [320]. It is clear from the in vivo
and in vitro studies that IRF8 promotes the commitment of myeloid progenitors along the
macrophage lineage at the expense of the granulocyte lineage.
The  homologue  of  irf-8  was  identified  in  rainbow  trout  [321]  and  zebrafish  [322]  with
53-55% amino acid  identity  to  human IRF8 [321,  322].  In  trout  tissues,  irf8  mRNA was
detected  in  the  spleen,  head  kidney,  gill,  brain,  intestine,  skin,  muscle,  and  liver  [321]
and  mRNA  levels  could  be  up-regulated  in  splenocytes  upon  treatment  with  Poly  I:C,
PMA, PHA and recombinant IL-15.  However,  the role of IRF8 in GMP fate decisions or
during macrophage development was not assessed. In zebrafish developing embryos, irf8
mRNA was first  detected in the rostral  blood island,  the site  of  primitive myelopoiesis,
and  was  co-expressed  with  csf-1r  mRNA,  but  not  in  cells  positive  for  mpx,  suggesting
that irf8 is expressed in cells committed to the macrophage lineage [322]. In zebrafish irf8
morphants,  csf-1r+  cells  were  absent,  while  mpx+  cells  and  mature  neutrophils  were  in‐
creased by approximately three-fold,  suggesting IRF8 is  required for macrophage devel‐
opment.  This  phenotype  could  be  rescued  by  injecting  embryos  with  irf8  mRNA.
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Conversely,  the  over-expression  of  irf8  mRNA  in  zebrafish  resulted  in  an  increase  in
macrophages by approximately 50% and a decrease in neutrophil numbers by about 40%
[322]. These data are similar to those of the mammalian system and suggest a conserved
role  for  IRF8  in  determining  macrophage  over  neutrophil  cell  lineage  during  primitive
myelopoiesis. However, whether IRF8 plays the same role during definitive myelopoiesis
in teleosts remains to be determined.
5.3.4. MafB
In  addition  to  the  previously  described  role  of  MAFB in  HSCs  and  CMPs  (see  section
4.3.1), MAFB is highly expressed in monocytes and macrophages [164, 323] and has been
shown  to  induce  differentiation  of  myeloblasts  into  monocytes  and  macrophages  [163,
307, 324, 325]. Furthermore, MAFB and c-MAF double knockout mice displayed differen‐
tiated macrophages that were capable of proliferating in response to CSF-1 in semi-solid
and liquid culture [325]. Therefore, it appears that MAFB expression is sustained in mon‐
ocytes and macrophages in order to prevent proliferation in these terminally differentiat‐
ed cell populations.
Studies examining the role of MAFB in teleost myelopoiesis are limited. In the goldfish PKM
system, a mafb transcript was identified and showed increasing mRNA levels with macro‐
phage development [19]. The increasing mRNA levels of mafb during macrophage differen‐
tiation are similar to what has been observed in mammalian systems and suggest that
MAFB may play a role in teleost macrophage differentiation.
6. Conclusion
Myelopoiesis is an orchestration of a multitude of growth factors and transcription factors
that control cell fate decisions and differentiation along a chosen cell lineage. It is evident
that there exists some functional redundancy in the action of myelopoietic growth factors,
most likely put in place to ensure the production of these critical innate immune cells. Stud‐
ies have focused on examining the regulation of myelopoiesis in the mouse model system,
and have only just begun in the teleost model system.
The divergence of teleosts and mammals occurred approximately 400-450 Mya, thus teleosts
represent one of the most basal groups of vertebrates [326]. Comparison of soluble factors
and their receptors in teleosts and mammals show retention of many of important hemato‐
poietic growth factors and receptors, including PDGFR [250, 251, 327], c-KIT [128-130], FLT3
(accession number DQ317446), CSF-1R [20, 250-254], GCSFR [292, 293], and their ligands
PDGF [328], KIT ligand [128, 130, 131], CSF-1 [246, 249], and GCSF [290-292], although
FLK2, the ligand to FLT3, has not yet been reported. However, it appears that teleosts do not
possess the key myeloid growth factors IL-3 and GM-CSF, and their cognate receptors. In
addition, teleosts possess all of the TF families required for hematopoiesis in higher verte‐
brates, reviewed in [28, 30]. Based on studies performed to date, the regulation of hemato‐
poiesis is largely similar between mammals and teleosts. However, teleosts often possess a
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number of gene duplications for many of the soluble factors, receptors, and to some extent,
transcription factors as a result of a teleost-specific whole genome duplication predicted to
have occurred approximately 350 Mya, and is believed to be responsible for the radiation of
teleosts [329, 330]. Many of these teleost genes are rapidly evolving, often undergoing sub-
functionalization or neo-functionalization making the identification of teleost orthologues
difficult. By developing an understanding of the soluble mediators, receptors, and the intra‐
cellular machinery that govern teleost myelopoiesis, we may be better equipped to develop
strategies to promote host defense against pathogens, particularly in aquaculture in which
fish are predisposed to infection.
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